SCHEMBL6169043

SCHEMBL6169043

O=c1o[nH]c2cc(Br)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.50
▸ JAK2 O60674 2/20 0.41
▸ CDK9 P50750 2/20 0.41
▸ CDK5 Q00535 2/20 0.41
▸ CAMK2A Q9UQM7 2/20 0.41
▸ DYRK1A Q13627 2/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ DAPK3 O43293 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ PAK4 O96013 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ NTRK1 P04629 1/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ RET P07949 1/20 0.41
▸ MET P08581 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ FGFR1 P11362 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16695822 0.84 PIM1 (0.50) METAP2JAK2CDK9CDK5CAMK2A
SCHEMBL10780015 0.76 DAO (0.52) LMNAHPGD
SCHEMBL13304413 0.76 LMNA (0.43) CHEK1PIM1RPS6KA3LMNAHPGD
SCHEMBL2382755 0.73 F2 (0.56) METAP2JAK2CDK9CDK5CAMK2A
SCHEMBL30549739 0.73 F2 (0.56) METAP2JAK2CDK9CDK5CAMK2A
SCHEMBL29440558 0.70 F2 (0.52) LMNAHPGD
SCHEMBL158747 0.70 F2 (0.52) LMNAHPGD
Methane SCHEMBL29008285 0.68 F2 (0.50) LMNAHPGD
SCHEMBL3526289 0.68 DAO (0.61) METAP2JAK2CDK9CDK5CAMK2A
SCHEMBL15333160 0.67 METAP2 (1.00) METAP2JAK2CDK9CDK5CAMK2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015065338-A1 QUINAZOLINE BASED RESPIRATORY SYNCYTIAL VIRUS INHIBITORS MEDIVIR AB (SE) 2015-05-07 — — WO disclosed
EP-1531812-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2005-05-25 — — EP disclosed
WO-2004010995-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-05 — — WO disclosed
Send feedback